PubMed Health⌕ Search

Biomedical subjects

George A Mansoor

Publications and source records attributed to George A Mansoor.

17 recordsLinked to original sources
PubMed2006

Orthostatic hypotension due to autonomic disorders in the hypertension clinic.

Hypertension specialists are consulted regarding orthostatic hypotension (OH) or the combination of OH with supine hypertension. These clinical presentations are often associated with a variety of underlying autonomic disorders. A comprehensive medical history and clinical examination with attention to autonomic signs and the neurological system may suggest the possible etiology or a differential diagnosis. At times, drug therapy for hypertension or other diseases such as Parkinson's is temporally associated with the onset of OH. At other times, no definitive association can be made. Most hypertension specialists can initiate basic evaluation and treatment. Treatment approaches to OH must be targeted primarily to alleviate symptoms of cerebral hypoperfusion and also be cognizant of supine hypertension. Several lifestyle and drug therapies can ameliorate symptoms of OH. Short-acting antihypertensive therapy may be useful in controlling nocturnal supine hypertension.

Autonomic Nervous System Diseases↗
PubMed2006

Primary hyperaldosteronism associated with hypertensive emergencies.

There is growing awareness of primary hyperaldosteronism as a cause of secondary hypertension. Usually, it manifests as hypertension and hypokalemia, or as resistant hypertension. Much less often, primary hyperaldosteronism may be detected after a hypertensive emergency has developed. We highlight this association by reporting on eight patients with a clinical diagnosis of primary hyperaldosteronism whose course was complicated by a hypertensive crisis. In all patients, an elevated serum aldosterone, was accompanied by a suppressed plasma renin activity despite the presence of a hypertensive crisis. A good outcome was obtained either with laparoscopic adrenalectomy (1 patient) or with an antihypertensive drug regimen that included an antialdosterone agent (7 patients). The differential diagnosis of hypertensive emergencies should include primary hyperaldosteronism.

Acute Disease↗
PubMed2005

Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases.

Herbal remedies, supplements, and alternative therapeutic items are used by many patients with hypertension and cardiovascular diseases. Scientific knowledge about their efficacy and safety is lacking, and unfortunately, physicians are frequently not aware that patients are using these nontraditional forms of medical care. Patients may anticipate physicians' disapproval of their use, or not realize that it is important for the physician to know what they are taking. Therefore, it is imperative that patients are asked nonjudgmental questions about current and past use of herbals and alternative therapies. Even when physicians are aware of such use, they feel poorly trained to identify the constituents and effects. Although many such therapies are innocuous, several herbal or alternative therapeutic items can significantly elevate blood pressure or cause interactions with cardiovascular drugs. Practitioners in cardiovascular medicine should be competent and know current scientific evidence for the benefits and adverse effects of herbal supplements and provide patients reasonable advice. In this brief article, we review the epidemiology of alternative therapy use, and select several important herbal or other supplements that patients with hypertension and cardiovascular diseases may be taking. We discuss the therapies considered biological in nature as opposed to mind-body interventions or manipulative body or energy therapies.

Cardiovascular Diseases↗
PubMed2004

Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy.

We prospectively studied the effect of spironolactone, an aldosterone antagonist, on endothelial function in patients with advanced congestive heart failure (CHF) using the brachial artery reactivity method. Twenty patients optimized on conventional CHF therapy were treated with spironolactone, and brachial artery flow- mediated dilation was measured at baseline and at 4 and 8 weeks. Spironolactone improved endothelial function at 4 weeks, and sustained the improvement at 8 weeks, in patients with CHF on conventional medical therapy, presumably due to reversal of aldosterone impairment of endothelial nitric oxide activity.

Aged↗
PubMed2004

Self-measured home blood pressure in predicting ambulatory hypertension.

BACKGROUND: Physicians are commonly uncertain whether a person with office blood pressure (BP) around 140/90 mm Hg actually has hypertension. This is primarily because of BP variability. One approach is to perform self-measured home BP and determine if home BP is elevated. There is a general agreement that if home BP is >/=135/85 mm Hg, then antihypertensive therapy may be commenced. However, some persons with home BP below this cut-off will have ambulatory hypertension. We therefore prospectively study the role of home BP in predicting ambulatory hypertension in persons with stage 1 and borderline hypertension. METHODS: We studied in a cross-sectional way home and ambulatory BP in a group of 48 patients with at least two elevated office BP readings. The group was free of antihypertensive drug therapy for at least 4 weeks and performed 7 days of standardized self-BP measurements at home. We examined the relationships of the three BP methods and also defined a threshold (using receiver operating curves) for home BP that captures 80% of ambulatory hypertensives (awake BP >/=135/85 mm Hg). RESULTS: Office systolic BP (145 +/- 13 mm Hg) was significantly higher than awake (139 +/- 12 mm Hg, P = .013) and home (132 +/- 11 mm Hg, P < .001) BP. Office diastolic BP (88 +/- 4 mm Hg) was higher than home diastolic BP (80 +/- 8 mm Hg, P < .001) but not different from awake diastolic BP (88 +/- 8 mm Hg, P = .10). Home BP had a higher correlation (compared with office BP) with ambulatory BP. The home BP-based white coat effect correlated with ambulatory BP-based white coat effect (r = 0.83, P = .001 for systolic BP; r = 0.68, P = .001 for diastolic BP). The threshold for home BP of 80% sensitivity in capturing ambulatory hypertension was 125/76 mm Hg. CONCLUSIONS: Our preliminary data suggest that a lower self-monitored home BP threshold should be used (to exclude ambulatory hypertension) in patients with borderline office hypertension.

Adult↗
PubMed2003

Blood pressure control in the hypertension clinic.

BACKGROUND: One effort to improve hypertension care in the United States is the development of the "Hypertension Specialist" program with appropriate training and certification of individual physicians. METHODS: We examined the impact of a hypertension clinic on blood pressure (BP) levels and control. RESULTS: By one year, BP declined 18/9 mm Hg, (P =.001) and BP control rates increased from 26% to 55% (P <.001) for systolic BP, from 47% to 82% (P <.001) for diastolic BP and from 18% to 52% (P <.001) for both. Age and systolic BP were significantly higher in uncontrolled patients. CONCLUSIONS: Attendance in a hypertension clinic significantly impacts BP control.

Adult↗
PubMed2003

Determinants of left atrial size in patients with newly diagnosed untreated hypertension.

The present study determined the relationships between ambulatory blood pressure, left ventricular mass, body mass index, and other clinical and demographic variables to left atrial size in previously untreated hypertensive and normotensive subjects. Left atrial size was measured uni-dimensionally using M-mode echocardiography in 58 newly diagnosed never-treated hypertensive patients (office blood pressure 149/96 +/- 15/7 mmHg) and 28 normotensive control subjects (office blood pressure, 122/78 +/- 8/8 mmHg). Left ventricular mass, septal and posterior wall thickness were significantly increased in hypertensive compared to normotensive subjects (230 +/- 63 g versus 181 +/- 45 g, 1.1 +/- 0.2 cm versus 0.94 +/- 0.2 cm, and 1.04 +/- 0.2 cm versus 0.92 +/- 0.2 cm respectively; all p < 0.001). Left ventricular internal diameter (4.9 +/- 0.6 versus 4.8 +/- 0.4 cm, = 0.54) and left atrial size (3.74 +/- 0.48 versus 3.70 +/- 0.34 cm, p = 0.86) were not different between the two groups respectively. Body mass index, weight, left ventricular mass, wall thickness, and 24-h pulse pressure were significant correlates of left atrial size in the entire group and in the hypertensive subgroup. In the normotensive subgroup, body weight, body mass index, 24-h systolic and pulse pressure, and left ventricular mass were significant correlates. Multiple regression analyses in the entire group and the hypertensive subgroup alone showed that body mass index and left ventricular mass were the two best predictors of left atrial dimension. These data demonstrate that body mass index and left ventricular mass were the main correlates of left atrial size in patients with previously untreated stage I-II hypertension.

Adult↗
PubMed2003

A practical approach to persistent elevation of blood pressure in the hypertension clinic.

Patients seen with persistent elevation of office blood pressure (BP) in the hypertension clinic are common and pose a significant challenge to the hypertension specialist. These are usually patients sent to the clinic because of difficulty in achieving BP goals. In this clinical setting there is usually data available from home self measurement and ambulatory BP readings. We propose a scheme to encourage specialists to consciously consider the causes of persistent elevation of office BP. The scheme relies initially on consideration that the measured office readings are falsely elevated due to pseudohypertension, small cuff size or other equipment problems. If this is not the case then the measured office BP is truly elevated. If so, a further distinction can be made in this group into those with (1). transient office BP elevation and normal home and/or ambulatory readings and (2). elevated office and out of office readings. The first subgroup is usually called white-coat hypertension but may also be seen with transient increases in BP due to talking or other factors. The second subgroup probably is the majority of patients with persistent high office BP and reflects sustained hypertension and its own list of causes including secondary hypertension. The nature and intensity of evaluation for secondary hypertension varies depending on the clinical presentation of the patient. We recommend an explicit consideration of reasons for persistent high office BP in the hypertension clinic.

Algorithms↗
PubMed2003

The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in haemodialysis patients.

OBJECTIVE: It is uncertain which blood pressure values (pre- or post-haemodialysis) best represent the average daily blood pressure in haemodialysis patients. The purpose of this study was to verify the power of peridialysis blood pressure to predict interdialytic blood pressure, and to ascertain the influence of blood pressure fluctuations during dialysis on this predictive ability. METHODS AND RESULTS: We performed ambulatory blood pressure monitoring during the interdialytic period on 60 stable haemodialysis patients (mean age 53 +/- 16 years, 33 male) between two mid-week haemodialysis sessions. Pre- and post-haemodialysis blood pressures were 154/82 and 142/77 mmHg, respectively, and 44-h interdialytic blood pressure was 136/77 mmHg. Overall, post-haemodialysis blood pressure values correlated with interdialytic ambulatory blood pressure marginally better than did pre-haemodialysis values (r = 0.52 versus 0.61 for pre- and post-dialysis systolic pressure, respectively; r = 0.67 versus 0.72 for pre- and post-dialysis diastolic pressure, respectively). The average of the pre- and post-haemodialysis values showed a slightly better correlation with interdialytic blood pressure (r = 0.65 and 0.75 for systolic and diastolic pressure, respectively). When we stratified patients according to systolic blood pressure behaviour during dialysis, pre-dialysis blood pressure was the stronger predictor of interdialytic blood pressure in the quartile with greatest intradialytic blood pressure fall (r = 0.67 versus 0.44 for pre- and post-dialysis systolic blood pressure, respectively), whereas post-dialysis values were substantially better in the group with a rise in systolic pressure during dialysis (r = 0.26 versus 0.59 for pre- and post-dialysis systolic blood pressure, respectively). CONCLUSIONS: These data demonstrate that peridialysis blood pressure values are of limited accuracy in predicting interdialytic blood pressure, post-dialysis values are minimally better predictors than pre-dialysis blood pressures, and the average of pre- and post-haemodialysis values is marginally better than both. In addition, blood pressure fluctuations during dialysis have a sizable impact on this predictive ability. Clinical decisions related to blood pressure management and research design in haemodialysis hypertension should take these factors into account.

Blood Pressure↗
PubMed2002

Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects?

Both basic and experimental data indicate that the renin-angiotensin system through angiotensin II mediates its classic hemodynamic role, but also has a significant deleterious role in a number of cardiac, vascular, and renal disorders. Indeed, evidence indicates that angiotensin II negatively impacts endothelial function, cardiac remodeling, vessel wall hypertrophy, atherosclerosis, and progressive renal disease. Newer data point to a significant role for angiotensin II in inflammation and in inducing plasminogen activator inhibitor. This widespread negative effect can be countered by newer antihypertensive drugs, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers. Both small and large clinical trials suggest a large benefit of such drugs on not only organ-specific endpoints such as renal disease or proteinuria, but on global cardiovascular events. It does appear that when blood pressure is significantly elevated, lowering blood pressure does indeed provide protection for larger endpoints such as stroke. However, at lower blood pressure levels, a hemodynamically independent effect is likely to be contributing to the positive effects. We should embrace these effects and champion them for our patients.

Angiotensin II↗
PubMed2002

Ambulatory blood pressure monitoring in clinical trials in adults and children.

Ambulatory blood pressure (BP) monitoring is a technique associated with several operational characteristics that make its use in adult hypertension trials attractive. To extend its use effectively to hypertension trials in children, additional studies are needed to assess its performance in this population. It is likely that ambulatory monitoring will be important in this population for the study of drug efficacy and safety. In general, ambulatory monitoring has better short-term and long-term reproducibility than office BP. Some data suggest that this superiority of ambulatory over office BP is also true in children. This better reproducibility should allow a drug effect to be detected with a smaller sample size, especially in crossover studies. Ambulatory BP averages are also free from the office-induced increase in BP, making it is easier to include adults and children in trials who have ambulatory hypertension. Such a requisite for a trial has to be planned to include more patients in the recruitment and run-in phases as use of an ambulatory criterion for hypertension will lead to some patients with elevated office BP not qualifying based on ambulatory readings. Of additional major importance, ambulatory monitoring of BP correctly identifies the temporal effects of a drug and hence allows accurate calculation of its trough-to-peak ratio. Ambulatory monitoring promises to be a significant tool for the study of hypertension in children including pathophysiology and the efficacy of antihypertensive drugs.

Adult↗
PubMed2002

Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning.

Primary aldosteronism is a disorder that is commonly considered in patients referred to the hypertension clinic. The ease of measuring the random aldosterone-to-renin ratio in conjunction with an elevated serum aldosterone level has led to an increased screening for this disorder. Typically, patients undergo a confirmatory test after a positive screening test. However, once primary aldosteronism is confirmed, subtype delineation is critical to decide on the optimal treatment. We report a patient with resistant hypertension and primary aldosteronism with a normal computed tomographic scan of the adrenal glands, a left-sided uptake on adrenal scintigraphy, and a right-sided lateralization of aldosterone after adrenal vein sampling. A repeat adrenal vein sampling confirmed the aldosterone lateralization to the right adrenal gland, which was then removed laparoscopically. The patient had a good clinical and biochemical response, and unilateral adrenal hyperplasia was discovered at histology. Excessive reliance on adrenal scintigraphy without adrenal vein sampling may lead to serious errors in patient management.

Adosterol↗
PubMed2002

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.

BACKGROUND: Therapeutic agents for the treatment of hypertension may differ in their efficacy during the early-morning period, a time when both morbid and mortal cardiovascular events are increased compared with other times of the day. METHODS: We studied the effects of a chronotherapeutic delivery system of verapamil (controlled-onset extended release [COER]-24 system) dosed at bedtime versus conventional morning administration of both enalapril and losartan on the blood pressure (BP), heart rate, and the heart rate systolic BP product during the first 4 hours after awakening in a placebo-controlled, forced-titration trial. There were 357 men and women enrolled in the trial with an untreated sitting diastolic BP of 95 to 114 mm Hg and ambulatory daytime diastolic BP > or =85 mm Hg. Patients were randomized to either COER-verapamil hydrochloride each evening (240 mg titrated to 360 mg), enalapril each morning (10 mg titrated to 20 mg), losartan each morning (50 mg titrated to 100 mg), or placebo. Early morning assessments of BP, heart rate, and the heart rate systolic BP product were performed by use of 24-hour ambulatory recordings after 4 weeks (low dose) and 8 weeks (high dose) of therapy. RESULTS: Results were similar at weeks 4 and 8 for all treatment groups except that the magnitude of change was greater at week 8. After 8 weeks of treatment, reductions in early morning BP by COER-verapamil were significantly greater (-15/-10 mm Hg) than enalapril (-9/-7 mm Hg, P <.01) and losartan (-8/-5 mm Hg, P <.001). COER-verapamil also led to greater reductions in morning heart rate, the rate-pressure product, and the rate-of-rise of BP compared with the other 2 active treatment groups. Reductions in mean 24-hour BP were greater in patients treated with COER-verapamil compared with placebo and losartan, and similar to reductions in patients treated with enalapril. CONCLUSIONS: Bedtime administration of an agent designed to parallel the circadian rhythm of BP and heart rate led to significantly greater early morning hemodynamic effects compared with other conventional once-daily antihypertensive agents dosed in the morning.

Antihypertensive Agents↗
PubMed2002

Stroke associated with alpha blocker therapy for benign prostatic hypertrophy.

Benign enlargement of the prostate is a malady of older males, reaching an estimated prevalence of 90% in patients aged over 70 years. Many of these patients are treated with alpha blockers, which can lower blood pressure significantly. We report on a 64-year-old man who developed a right hemiparesis after taking one dose of doxazosin 4 mg for prostatic symptoms. A CT scan of the brain and carotid ultrasound studies were normal. He recovered most of his neurological function within a few days. Ambulatory blood pressure monitoring on doxazosin 2 mg revealed a striking sleep blood pressure reduction.

Adrenergic alpha-Antagonists↗
PubMedDate not supplied

Comprehensive management of hypertensive emergencies and urgencies.

Despite advances in chronic hypertension management, hypertensive emergencies and urgencies remain as serious complications. Much of this relates to poor compliance with effective antihypertensive management. Hypertensive emergencies and urgencies can also be seen as the initial manifestations of hypertension in pregnancy and in the perioperative period. Multiple classes of intravenous antihypertensive drugs are available to treat hypertensive emergencies, and specific agents may have an advantage in a given clinical situation. Orally active agents are used to treat hypertensive urgencies, and include clonidine, angiotensin-converting enzyme inhibitors, and labetalol. Most patients respond to drug therapy, but problems may arise related to a rapid normalization of blood pressure.

Administration, Oral↗
PubMedDate not supplied

History of major depressive disorder and endothelial function in postmenopausal women.

OBJECTIVE: To determine whether history of depression is associated with endothelium-dependent flow-mediated dilation (FMD) in postmenopausal women. METHODS: Thirty-nine postmenopausal women with no known or suspected cardiovascular disease participated. Nineteen had a positive lifetime history of major depressive disorder, and 20 were never depressed. None were currently depressed, and all had been free of major depressive disorder and antidepressant medications for > or =1 year. History of depression was assessed with the Structured Clinical Interview for DSM-IV, enhanced by a modified version of the timeline follow-back method. Current depressive symptoms were measured with the Center for Epidemiological Studies Depression scale (CES-D). Brachial artery FMD was measured with ultrasound and calculated as percent dilation from baseline. RESULTS: After controlling for current subclinical depressive symptoms, ethnicity, hormone replacement therapy, and presence of the metabolic syndrome, previously depressed women showed significantly and clinically meaningful lower FMD than never depressed women. Controlling the same covariates, there was a dose-response relationship between number of depressive episodes and FMD. Examination of FMD means showed a significant negative correlation between number of depressive episodes and FMD. CONCLUSION: In postmenopausal women, depression continues to show a negative relationship to endothelial functioning even after years of remission. This relationship is not accounted for by residual depressive symptoms. Implications pertain to exclusion of previously depressed persons from control groups in research exploring the relationship between depression and cardiovascular disease.

Aged↗